ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TSTL Tristel Plc

455.00
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tristel Plc LSE:TSTL London Ordinary Share GB00B07RVT99 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 455.00 450.00 460.00 455.00 455.00 455.00 2,516 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 36.01M 4.46M 0.0941 48.35 215.67M

Tristel PLC Trading update & Notice of results (4226L)

19/07/2017 7:00am

UK Regulatory


Tristel (LSE:TSTL)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Tristel Charts.

TIDMTSTL

RNS Number : 4226L

Tristel PLC

19 July 2017

Tristel plc

("Tristel" or "the Company")

Trading update & Notice of results

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, provides a trading update for the year ended 30 June 2017 in conjunction with today's Shareholder Open Day at its headquarters in Snailwell, Cambridgeshire.

For the year ended 30 June 2017 Tristel will record turnover in excess of GBP20 million (2016: GBP17.1 million) and pre-tax profit (before share-based payments) of at least GBP4 million (2016: GBP3.3 million). Both turnover and pre-tax profit are ahead of market expectations. In the second half, revenue from overseas markets contributed 50% of the Group total compared to 43% in the first half, and for the full year overseas revenue represented 47% of Group revenue - a record level. Tristel has continued to generate significant levels of cash and at 30 June 2017 cash balances were GBP5.1 million (30 June 2016: GBP5.7 million). The Company has no debt.

During the year ended 30 June 2017, the Company spent GBP0.95 million on the acquisition of its Australian distributor, distributed an aggregate GBP2.8 million in dividends including a special dividend announced in July last year, incurred costs of GBP0.5 million in association with its North American market entry - the fruits of which were announced earlier in the month with our first submission to the EPA. The Company also invested US$0.75 million in Mobile ODT, a business combining smartphone technology with hand-held medical devices for point-of-care diagnostics.

The Company will declare a final dividend for the year at the time of the preliminary results to be announced in October. The Board is currently considering its dividend policy and the ongoing cash requirements of the business as it continues its global expansion.

Shareholder Open Day

Tristel is today hosting an Open Day for Shareholders at the Company headquarters in Snailwell, Cambridgeshire. A presentation will be made during the Open Day; however, it will contain no new material information and will be available on the Company website: www.tristel.com/investor-centre

Notice of results

The Company expects to announce its preliminary results for the year ended 30 June 2017 on 19 October 2017.

Francisco Soler, Chairman of Tristel plc, comments: "The Company enjoyed a very strong second half with overseas sales continuing to drive progress. The Australian acquisition that we announced at the Open Day event in July last year made a significant contribution to this growth and we consider it as having been a success. We are pleased that overseas sales in the year represented almost half of the total and we anticipate that our overseas operations will continue to expand."

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014

For further information please contact:

 
 Tristel plc                                   Tel: 01638 721 500 
 Paul Swinney, Chief Executive Officer 
 Liz Dixon, Finance Director 
 
 Walbrook PR Ltd     Tel: 020 7933 8780 or tristel@walbrookpr.com 
 Paul McManus                                  Mob: 07980 541 893 
 Lianne Cawthorne                              Mob: 07854 391 303 
 
 finnCap                                       Tel: 020 7220 0500 
 Geoff Nash/ Giles Rolls (Corporate Finance) 
 Alice Lane (Corporate Broking) 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

TSTZVLFFDDFEBBE

(END) Dow Jones Newswires

July 19, 2017 02:00 ET (06:00 GMT)

1 Year Tristel Chart

1 Year Tristel Chart

1 Month Tristel Chart

1 Month Tristel Chart

Your Recent History

Delayed Upgrade Clock